Introduction

Material and Methods
Percutaneous transluminal angioplasty (PTA) is the Between October 1990 and December 1994, 87 limbs treatment of choice for patients with symptomatic in 82 patients were treated by the percutaneous placeconcentric non-calcified short stenoses of the aortoiliac ment of endovascular metal stents for symptomatic arterial segment. 1 Resistance to dilatation, elastic recoil, occlusive disease of the aortic and iliac segment. All flow-limiting dissection, thrombosis or spasm may patients' medical charts including interventional treatresult in failed PTA. Late restenosis may be due to ment records were reviewed. It was not possible retrointimal hyperplasia, progressive disease or arterial spectively to analyse the material on an intention-toremodelling. 2 During the last decade, the percutaneous treat. Demographic data are presented in Table 1 . placement of metallic stents has been established as a Using the Fontaine classification, 12 two patients had complementary procedure in the setting of an un-stage IIa disease (intermittent claudication with a walksatisfactory PTA.
3-10 Stent placement has also been ing distance >200 m), 52 had stage IIb disease (walking used in the treatment of chronic arterial occlusions distance <200 m), 14 had stage III disease (rest pain) and complex lesions, i.e. long, multiple, eccentric and/ and 14 had stage IV disease (tissue loss). One patient or calcified stenoses. 11 The aim of this retrospective with stage IV disease was treated because of microstudy was to evaluate our long-term results of stent embolism, i.e. ''blue toe syndrome''. treatment in aortoiliac occlusive disease. Additionally, There were 63 stenoses and 24 occlusions. The aetipredictive factors influencing clinical outcome of the ology of the lesions were atherosclerosis in 74 patients, procedure were identified.
restenosis after previous PTA in six, anastomotic stenosis of an aortobi-iliacal graft in one, and one patient * Please address all correspondence to: P. Uher, Department of was considered to have Takayasu arteritis. The charRadiology, Malmö University Hospital, University of Lund, S-205 02 Malmö , Sweden.
acteristics of the lesions are presented in Table 2 . Three by the administration of 10-20 IU/kg boluses heparin each hour. Arteriography of the distal vessels was not performed routinely post-stenting due to concerns patients had lesions involving the aortic bifurcation regarding the amount of contrast medium used, presand origin of both common iliac arteries (CIA). Two ence of impaired renal function and/or diabetes melpatients had isolated aortic occlusions and one a stenlitus. osis.
Additional interventions were performed in 19 A lesion was considered haemodynamically sigpatients. These included femorofemoral cross-over nificant if (1) the lumen diameter reduction was [75% grafting (n=6), thromboendarterectomy of the deep or compared to an adjacent normal vessel segment, 13 common femoral artery (n=4), femoropopliteal bypass (2) the trans-stenotic mean arterial blood pressure (n=3), PTA of the superficial (n=2) and deep femoral gradient at rest was [10 mmHg or (3) there was a artery (n=1), ilioprofundal bypass with an exclusion [15% decrease in systolic pressure index (arterial of a post-surgical pseudoaneurysm of the deep femoral pressure distal to the lesion/arterial pressure proximal artery (n=1), endoluminal stent-graft placement due to the lesion) after injection of 30 mg papaverine distal to a subtotal occlusion of the external iliac and common to the stenosis 14 in claudicants with a <10 mmHg mean femoral artery (n=1), and percutaneous aspiration of gradient at rest. peripheral emboli present prior to stent placement and Primary stenting was performed in 24 occlusions, originating from a stenotic iliac artery (n=1). These 27 eccentric and/or heavily calcified stenoses and 6 interventions were performed at the same setting as restenoses after previous PTA. Secondary stenting, stent placement in 5 patients (PTA of superficial femfollowing a failed PTA, i.e. a persisting significant oral artery (n=3), thromboendarterectomy of deep trans-stenotic pressure gradient, markedly decreased femoral artery (n=1) and aspiration of peripheral blood flow and/or a poor anatomical result (residual emboli (n=1)) and at different occasions in 14 patients. stenosis [50%), was performed due to dissection in In 13 patients the outflow procedure was planned, 21 and elastic recoil in nine arteries. and in the remaining 6 patients it was performed when Wallstents (Schneider, Bü lach, Switzerland) were it was evident that the stent implantation alone was placed in 47 limbs, Palmaz stents (Johnson & Johnson Interventional Systems, Warren, NJ, U.S.A.) in 22, not enough to relieve the symptoms. Technical success was defined as smooth apposition our experience resulted in an obstructive dissection of the stent to the vessel wall judged from ar-extending into the CIA. Subsequent stent treatment teriography with a residual lumen diameter reduction failed because it did not cover the entire dissection. The of Ζ30% and a mean trans-stent pressure gradient patient required aortobifemoral grafting two months <10 mmHg. Antiplatelet therapy was initiated after later. Stents were incorrectly deployed in two limbs, stent deployment with the daily administration of but endovascular salvage was accomplished with ad-75-160 mg acetylsalicylic acid. Patients with ex-ditional stenting. Periprocedural thrombosis of stents ceptionally poor peripheral run-off were given post-occurred in three limbs. The acute events were atprocedural heparinisation for period of 1-3 days.
tributed to insufficient heparinisation in one patient, Clinical success was defined as an improvement in a possible hypercoagulable state in a patient with at least one category in stage 2 and 3 disease and an ovarian carcinoma, and in one patient following by two categories in stage 4 disease in the Fontaine recanalisation of an occluded distal aorta and biclassification system and the improvement of the furcation. All occlusions were successfully treated with ankle-brachial index (ABI) by more than 0.1. Clinical success was obtained in 73 of 82 patients (36 limbs) and duplex ultrasound (8 limbs) over a (77 of 87 limbs; 89% CI 80-94%). In 10 of the 77 limbs median period of 13.2 months (range 1-66 months). ABI measurements were missing. Clinical failures inIndications for arteriography were symptom re-cluded one technical failure mentioned above and currence (n=17), scheduled follow-up (n=12), per-two patients without improvement of their symptoms sistent symptoms (n=3) and contralateral symptoms despite an increase of ABI in one and angiographically (n=4).
proved patency of the stent in the other. Their sympCriteria according to Rutherford et al. were used toms were regarded as non-ischaemic. Another six to define patency of the stented vascular segment. 15 patients (7 limbs) did not improve after stent placeRecurrence of symptoms on routine clinical follow-ment; five of them due to poor run-off, i.e. arup prompted radiologic re-evaluation. Patients with teriographic occlusion of at least one femoral artery either arteriographic evidence of restenosis ([50% and all infrapopliteal arteries. Three of these patients diameter reduction 9,16 or a trans-stenotic pressure required a below-the-knee amputation and the other gradient which was successfully treated with two died; one, seven days after the stent placement supplemental interventions constituted an assisted due to progressive bilateral foot and lower leg ganprimary patency group. Reoccluded limbs sucessfully grene, and one after 42 days due to multi-organ failure. revascuralised with endovascular techniques defined In the sixth patient a femorofemoral cross-over graft the secondary patency group. The Kaplan-Meier following the stent procedure resulted in occlusion of method was used to determine the cumulative patency an old femoropopliteal graft, severe ischaemia, myorates of the limbs with iliac atherosclerotic lesions. 16 cardial infarction and the patient's death. The relationship between primary patency and the There were three early (Ζ30 days) clinical failures. following risk factors was evaluated: ischaemic heart Two patients presented with thrombosis of primarily disease, diabetes mellitus, current smoking, symptom stented occlusion, one of the CIA and one of the EIA. severity, ABI, patency of superficial femoral artery Intra-arterial thrombolysis failed in both cases. An (SFA), lesion type, lesion site and length. Variables incompletely treated EIA and CIA dissection resulted were tested using a univariate analysis comparing two in the third clinical failure. All three patients were survival curves with the Peto-Peto-Wilcoxon test. The treated with a femorofemoral bypass graft. Cox proportional hazard multivariate analysis was There were 12 late failures (eight restenoses and used to evaluate the prognostic value of the risk factors four occlusions), which occurred at a median time of with p<0.20 (Tables 4 and 5 ). The StatView∈ software 10.3 months (range 1.4-26.1) after initial stent place-(Abacus Concepts, Inc., CA, U.S.A.) was used for the ment. The restenoses, all within the stented part of the statistical analysis.
vessel, were treated with PTA in six cases and with additional stent placement in two. One occlusion was treated with thrombolysis followed by PTA of an Results underlying restenosis within the stent, one with thrombolysis and additional stent placement because of Stent placement was primarily successful in 81 of 87 limbs. PTA of an external iliac artery (EIA) early in progression of proximal atherosclerotic disease, and three-year primary and secondary patency rates for the whole group were 67 and 82%. The pretreatment ABI and the lesion length were the only factors that were found to be independently predictive of primary patency outcome in iliac atherosclerotic lesions (Tables  4 and 5 ). The cumulative one-year primary patency rates for limbs with ABI <0.50 (median value) was 63%, compared with 83% in limbs with ABI [0.50 (p=0.05). In limbs with lesions longer than 3 cm the cumulative one-year patency rate was 50% compared with 84% in limbs with lesions 3 cm long or shorter (p=0.007, Peto-Peto-Wilcoxon test, Table 4 ). out any fatalities (7.3%, 95% CI 3-15%). There were three groin haematomas requiring surgical therapy one occlusion was left untreated. One patient died of (n=2) or transfusion (n=1). One patient suffered a heart failure three days after the occlusion had been myocardial infarction. Two diabetic patients (one with diagnosed. Reocclusion occurred in three of the 10 a renal transplant) developed persistent renal failure, treated limbs at 14, 15 and 30 months following the but neither required dialysis (increase of serum cresecond endovascular reintervention. One patient was atinine from 136 to 300 mol/l and 130 to 400 mol/l treated with second PTA, one with an ipsilateral ilirespectively). ofemoral bypass graft, and one patient was left unMinor complications were noted in five patients treated. In summary, recurrent disease within the (6.1%, 95% CI 2-14%). These included four groin haemtreated vascular segment occurred in 15 of the 73 atomas and a single asymptomatic embolus to a branch initially successfully treated patients requiring 13 perof the deep femoral artery. None required therapy, cutaneous and four surgical reinterventions. Fourteen and hospital stay was not prolonged in this group of of these recurrent lesions were in patients treated for patients. iliac atherosclerotic disease and one in a patient treated
The 30-day mortality rate was 3.7% (95% CI 1-10%). for restenosis after previous PTA.
Deaths resulted from myocardial infarction (n=2) folFive patients required below-the-knee amputations lowing surgical reconstruction and progressive bi-(5.6%, 95% CI 2-13%) at a median time of 2 months lateral lower extremity gangrene (n=1). (range 0.2-6 months). Three amputations occurred among the initial clinical failures described above. In the remaining two patients the stented artery was patent and the amputation was performed due to Discussion distal progression of atherosclerotic disease.
The cumulative one-and three-year primary patency During the last 20 years PTA of aortic and iliac atherosclerotic occlusive lesions has become widely acrates of atherosclerotic iliac arteries (n=77) were calculated to be 75 and 61% respectively, and secondary cepted as an alternative to bypass grafting in selected patients. 12 However, restenosis rates of 10-40% have patency 84 and 76% (Table 3 , Fig. 1 ). The cumulative been noted. 12, 17 Complex lesions including heavily cal-our data demonstrated that only the preprocedural ABI and the length of the lesion were statistically cified stenoses, long eccentric lesions and iliac occlusions respond less favourably to PTA. 1 The results significant in predicting patency. The presence of a stenosis rather than an occlusion, stent diameter, smokof the present retrospective study demonstrate that safe and effective treatment of complex aortoiliac le-ing and SFA disease were not helpful in predicting sustained clinical success. sions can be accomplished with stenting. At three years the primary, primary assisted and secondary There are few reports describing the use of stents in isolated atherosclerotic infrarenal aortic lesions. [23] [24] [25] patency rates of atherosclerotic iliac artery lesions were 61, 67 and 76%, respectively. In addition, there were Primary and secondary patency rates, during a mean follow-up period of 15 to 19 months, were 86 and no procedure-related mortalities and only 3 of 82 patients (3.7%, 95% CI 1-10%) suffered any com-100% respectively. Two of the authors reported no major complications, while one 23 had 21 per cent inplication with permanent sequelae.
Our patency rates were somewhat lower than re-cidence of major complications. The suggested indications for stent placement in isolated aortic lesions ported by others. In a large multicentre iliac stent trial Palmaz et al.
8 demonstrated a clinical and ar-have been: unsuccessful PTA, late recurrent stenosis, chronic occlusions, intraluminal atherosclerotic debris, teriographic patency rate of 90% and 94% respectively at 12 months. Vorwerk reported a 95% primary patency stenotic graft anastomosis, and eccentric, calcified or irregular lesions. We stented three isolated aortic lerate at one year and 82% at four years in the treatment of failed PTA of iliac stenoses. Secondary patency rates sions and did not observe any complications. All three patients had resolution of their symptoms. Although of 96% and 91% were noted at one and four years respectively. Recanalisation followed by primary stent aortic PTA has been shown to be safe and effective, primary stenting may prevent distal embolisation. placement in chronic iliac artery occlusions resulted in primary and secondary patency rates of 78% and Aortic stents also prevent recoil which permits underdilatation of heavily calcified lesions, thereby de-88% at four years.
10, 18 The multicentre Wallstent trial calculated the primary and secondary clinical patency creasing the risk of aortic rupture. 25 Historically aortobifemoral bypass surgery has had a rates to be 81% and 91% at one year and 71% and 86% at two years.
9 Strecker et al. reported primary patency higher patency rate at five years ranging from 80-95%, compared to angioplasty and stent placement. Howrates of 85% at three years and 79% at five years.
19
The majority of our technical failures and early ever, the reported early mortality (1% to 5%) and morbidity (9% to 20%) 26, 27 of surgery is substantially occlusions occurred early in our experience. The causes included incomplete sealing of dissections, inaccurate higher than for endovascular procedures. The most common early surgical complications are haemorrhage stent deployment and insufficient procedural anticoagulation. In three patients, dissections following (1-2%), limb ischaemia (1-10%), renal failure (4-8%), and intestinal ischaemia (1-2%). In addition, late PTA were incompletely covered; two of them required surgical interventions and one lesion required ad-complications include anastomotic pseudoaneurysms (1-5%), graft infection (1-2%), aortoenteric fistula ditional stenting following a recurrent stenosis 3 months after the initial procedure. We concluded that (0.4-2.4%) and neurogenic impotence (25%). 28 In a literature review of 6620 patients undergoing aortoiliac it is advisable to cover lesions completely and seal all dissections.
7 Another reason for our lower patency PTA the complication rate was 8.1%. 29 Major complications occurred in only 2.7%, with only 1.2% refigures may be the inclusion of five compassionate cases with extremely poor run-off, three of whom quiring surgery and the mortality rate was 0.2%, about one-tenth of that reported for surgical reconstructions. underwent amputation and two died.
Late (>30 days) stent occlusions may result from The most common complications were puncture site haematoma (2.9%), pseudoaneurysm/AV-fistula intimal hyperplasia, vessel remodelling or progressive atherosclerotic disease. Potentially negative prognostic (0.5%), acute arterial occlusion (1.9%), distal embolisation (1.6%) and renal dysfunction (0.7%). Arterial factors have included: incomplete covering of the lesion, length (>60 mm) of the stented segment, complete rupture at the site of PTA occurred in only 0.2% of the patients. Clearly, many of the complications of occlusion, SFA occlusion, stenting of the EIA, stent diameter less than 8 mm, and continued smoking. [19] [20] [21] angioplasty can be managed with adjunctive endovascular interventional procedure including adPatency rates in iliac segments treated with PTA alone have been related to the site of PTA, quality of peri-ditional stenting for acute occlusions due to dissection, thrombolysis for acute thrombosis, aspiration of distal pheral run-off, diabetes mellitus and treatment indication (claudication vs. rest pain). 22 Assessment of emboli, and stent-graft treatment for arterial ruptures.
